Genesis Capital completed the acquisition of Crux Biolabs.

Genesis Capital, a private equity firm, completed the acquisition of Crux Biolabs, a laboratory. Financial terms were not disclosed. "By bringing Genesis Capital on as an investor. we believe we have a partner with significant sector experience that will help us meet step-change demand and continue to provide industry leading testing services that we are known for," Scott Needham, Leading Technology CEO,